Charlotte Robinson

DocwireNews

Interwell Health, a kidney care management company that provides holistic, value-based care, recently conducted a <a href="https://www.interwellhealth.com/insights/managing-depression-in-patients-with-chronic-kidney-disease-to-slow-progression" target="_blank" rel="noopener">data analysis</a> suggesting that there are substantial benefits to identifying depression in patients with chronic kidney disease (CKD), thereby enabling treatment and follow-up.The results were dramatic when depression was spotted and a comprehensive care plan to address mental health was executed: In a review of 1561 patients identified with signs of moderate to severe depressive symptoms in 2022, more than 71% improved to mild or no depressive symptoms during a subsequent screening. By allowing for appropriate interventions, screening for depression in patients with CKD can improve overall well-being, slow disease progression, reduce hospitalizations, and lower the total cost of care, Interwell believes.Involving nephrology practices in depression screening may not be a standard practice, but it seems logical given that research has shown a link between CKD and depression, and the US Preventive Services Task Force recommends depression screening for all adults. &ldquo;If we can understand the link between depression and kidney disease and treat that, then we&rsquo;re more likely to be successful in treating the patient&rsquo;s [CKD],&rdquo; said Jessica Demaline, senior vice president of health care operations at Interwell Health and a licensed social worker. &ldquo;Physical conditions, including kidney disease, can be made worse by poor mental health or poor behavioral health.&rdquo;Screening, of course, is only the first step. As a provider of holistic care, Interwell Health can also connect patients to treatment resources. &ldquo;We have an interdisciplinary team that includes clinical social workers who sometimes assist the patients with social determinants of health, maybe socioeconomic or cultural barriers,&rdquo; Demaline explained. &ldquo;They also can provide virtual supportive counseling to patients or connect them with local community resources.&rdquo;Nephrologists also receive training on identifying and helping to coordinate treatment for depression. &ldquo;That is very challenging and not something that I would say nephrologists always are comfortable doing without some additional support,&rdquo; Demaline said. It has proven to be important, though, particularly in rural areas where community resources are limited. &ldquo;We embed coordinators in nephrology offices, and then we are able to assist the nephrologists by providing them with resources and treatment guidelines so that they can help patients who might otherwise go undiagnosed, untreated, or undertreated because of the lack of resources in the community.&rdquo;This is a model that other kidney care providers could adopt. &ldquo;We do see that some other companies focus on starting to treat the patient once they&rsquo;ve seen a nephrologist,&rdquo; Demaline remarked. Yet she sees an opportunity to identify and start treatment even earlier.Interwell uses proprietary predictive models to detect and treat kidney disease earlier, which also provides an opportunity to treat depression earlier. &ldquo;We feel like we need to go further upstream, be more proactive, and reach out to patients who may have never seen a nephrologist to start that nephrology care and that holistic care model that includes assessing and treating depression and social determinants of health,&rdquo; Demaline said.

BMI Modifies the Relationship Between Glycemic Status and Asthma Severity in Children

Asthma

Jordana Jampel

Cutaneous Melanoma: Sun Protection Behaviors and UV Exposure in Canada

Melanoma

Leah Lawrence

Significant Cardiac Benefit Seen With Ifetroban in Patients With Duchenne Muscular Dystrophy

Neurology

Latest News

How Kidney Care Providers Can Play a Role in Depression Screening—and Why It Matters

Chronic Kidney Disease

Kidney care providers can play a role in depression screening and thereby help improve outcomes for patients with chronic kidney disease (CKD).

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe